Acquisition - February 11, 2022
AegirBio and Dynamic Code discontinues their acquisition discussions
The basic conditions has changed and due to the current stock exchange developments it is not possible to carry out the deal. Read more: AegirBio to acquire Dynamic Code Photo of Anne Kihlgren, founder of Dynamic Code
Acquisition - February 3, 2022
Recipharm acquires GenIbet
Recipharm has announced the acquisition of GenIbet, a Portuguese CDMO, specializing in the manufacture of biological clinical trial material and novel modalities such as viral vectors, RNA and microbiome. The acquisition forms part of Recipharm’s strategy to grow in the biologics market, with a particular focus on drug substance manufacturing of novel ATMPs, the company […]
Acquisition - January 14, 2022
Observe Medical acquires Biim Ultrasound
Observe Medical and the shareholders of Biim Ultrasound have announced a definitive agreement whereby Observe Medical will acquire 100% of the shares in Biim Ultrasound. The transaction, which values Biim Ultrasound at approximately NOK 185 million (EUR 18.5 million), will be settled in cash and shares. The agreement further strengthens Observe Medical’s position as a […]
Acquisition - January 5, 2022
Immunicum transfers patent rights to Elicera
Immunicum has announced to transfer its patent rights for modified adenovirus (patent US 9,017,672 B2) to Elicera Therapeutics. The patent is currently out-licensed to Elicera and covers a modified adenovirus that improves gene delivery and tumor cell killing efficiency. “We are happy to enable Elicera to strengthen its patent position for its lead program while […]
Acquisition - December 6, 2021
Aqilion acquires anti-inflammatory program from LEO Pharma
Aqilion has strengthened its pipeline with an innovative development program in the field of chronic inflammation. With this acquisition, Aqilion is taking over all rights to the program, now under the name Regulus, from LEO Pharma. The project is ready for clinical trials and Aqilion plans to begin clinical development in 2022. Aqilion will make an […]
Acquisition - December 5, 2021
Advent withdraws its Sobi bid
The company in September agreed to an 8 billion USD takeover by Advent and Aurora, an investment vehicle of Singapore’s GIC Pte Ltd, through Agnafit Bidco. “Since the acceptance level condition has not been fulfilled, Agnafit Bidco hereby withdraws the offer,” Agnafit Bidco said in a statement. Commenting on the bid process, the Chairman of […]
